Rize University Report issue

Academic/Hospital Phase 4

Organization Overview

First Clinical Trial
2008
NCT01569256
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2017

Timeline

NOW
  • Now

Alternative names

Rize Üniversitesi | Rize University, Faculty of Medicine

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Hypothermia (Phase 4)

Nasal Polyps (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 3
  • # of Trial APIs: 5